Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lerong Li

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Biomed Research International|September 9, 2015
Dynamic Model for RNA-seq Data AnalysisLerong Li, Momiao Xiong
Pharmaceutical Statistics|March 27, 2025
Multiple Comparisons Procedures for Analyses of Joint Primary Endpoints and Secondary EndpointsXiaolong Luo, Lerong Li, Oleksandr Savenkov, et al.
Antioxidants (Basel, Switzerland)|April 14, 2025
A Fluorescent Probe for Imaging and Treating S-Nitrosation Stress in OGD/R CellsHui Ye, Chen Zhang, Lerong Li, et al.
Journal of Cell Science|June 11, 2017
HIRA deficiency in muscle fibers causes hypertrophy and susceptibility to oxidative stressNicolas Valenzuela, Benjamin Soibam, Lerong Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2017
Targeting AXL and mTOR Pathway Overcomes Primary and Acquired Resistance to WEE1 Inhibition in Small-Cell Lung CancerTriparna Sen, Pan Tong, Lixia Diao, et al.
Cancer Informatics|May 21, 2016
Selecting Reliable mRNA Expression Measurements Across Platforms Improves Downstream AnalysisPan Tong, Lixia Diao, Li Shen, et al.
Cancer Immunology Research|January 18, 2018
TUSC2 Immunogene Therapy Synergizes with Anti-PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic <i>Kras</i>-Mutant Mouse Lung Cancer ModelsIsmail M Meraz, Mourad Majidi, Xiaobo Cao, et al.
Nature|June 6, 2024
Publisher Correction: Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemiaDwight Koeberl, Andreas Schulze, Neal Sondheimer, et al.
Nature|April 22, 2024
Author Correction: Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemiaDwight Koeberl, Andreas Schulze, Neal Sondheimer, et al.
Nature|April 3, 2024
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemiaDwight Koeberl, Andreas Schulze, Neal Sondheimer, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Biomed Research International|September 9, 2015
Dynamic Model for RNA-seq Data AnalysisLerong Li, Momiao Xiong
Pharmaceutical Statistics|March 27, 2025
Multiple Comparisons Procedures for Analyses of Joint Primary Endpoints and Secondary EndpointsXiaolong Luo, Lerong Li, Oleksandr Savenkov, et al.
Antioxidants (Basel, Switzerland)|April 14, 2025
A Fluorescent Probe for Imaging and Treating S-Nitrosation Stress in OGD/R CellsHui Ye, Chen Zhang, Lerong Li, et al.
Journal of Cell Science|June 11, 2017
HIRA deficiency in muscle fibers causes hypertrophy and susceptibility to oxidative stressNicolas Valenzuela, Benjamin Soibam, Lerong Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2017
Targeting AXL and mTOR Pathway Overcomes Primary and Acquired Resistance to WEE1 Inhibition in Small-Cell Lung CancerTriparna Sen, Pan Tong, Lixia Diao, et al.
Cancer Informatics|May 21, 2016
Selecting Reliable mRNA Expression Measurements Across Platforms Improves Downstream AnalysisPan Tong, Lixia Diao, Li Shen, et al.
Cancer Immunology Research|January 18, 2018
TUSC2 Immunogene Therapy Synergizes with Anti-PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic <i>Kras</i>-Mutant Mouse Lung Cancer ModelsIsmail M Meraz, Mourad Majidi, Xiaobo Cao, et al.
Nature|June 6, 2024
Publisher Correction: Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemiaDwight Koeberl, Andreas Schulze, Neal Sondheimer, et al.
Nature|April 22, 2024
Author Correction: Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemiaDwight Koeberl, Andreas Schulze, Neal Sondheimer, et al.
Nature|April 3, 2024
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemiaDwight Koeberl, Andreas Schulze, Neal Sondheimer, et al.
Pageof 3